Inventor profile of:

Eckhard R. Podack

City:

Coconut Grove, Florida

Country:

United States

Published Applications:

27

Last publication date:

2023-02-02

Top Assignees for applications by Eckhard R. Podack

The entities that hold a legal rights for patent applications filed by inventor Podack Eckhard R.:

Recent patent applications by Podack Eckhard R.

Eckhard R. Podack from Coconut Grove, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-02-02
US20230034174A1
Human necessities

IMMUNOMODULATING TUMOR NECROSIS FACTOR RECEPTOR 25 (TNFR25) AGONISTS, ANTAGONISTS, AND IMMUNOTOXINS

#2 | 2020-11-05
US20200345809A1
Human necessities

Immunomodulating tumor necrosis factor receptor 25 (TNFR25) agonists, antagonists, and immunotoxins

#3 | 2019-06-13
US20190175706A1
Human necessities

TUMOR VACCINE

#4 | 2018-08-16
US20180230226A1
Chemistry; metallurgy

Method for in vivo expansion of T regulatory cells

#5 | 2018-03-22
US20180078611A1
Human necessities

Immunomodulating tumor necrosis factor receptor 25 (TNFR25) agonists, antagonists, and immunotoxins

#6 | 2017-08-10
US20170226218A1
Chemistry; metallurgy

Method for In Vivo Expansion of T Regulatory Cells

#7 | 2016-09-01
US20160250303A1
Human necessities

PERFORIN-2 ACTIVATORS AND INHIBITORS AS DRUG TARGETS FOR INFECTIOUS DISEASE AND GUT INFLAMMATION

#8 | 2016-02-18
US20160045583A1
Human necessities

Tumor vaccine

#9 | 2016-01-21
US20160015779A1
Human necessities

Immunomodulating tumor necrosis factor receptor 25 (TNFR25) agonists, antagonists, and immunotoxins

#10 | 2014-11-13
US20140335086A1
Human necessities

MODIFIED HEAT SHOCK PROTEIN-ANTIGENIC PEPTIDE COMPLEX

#11 | 2014-09-25
US20140286897A1
Human necessities

Compositions comprising TL1A-Ig fusion protein for the regulation of T regulatory cells, and methods for their use

#12 | 2014-07-10
US20140193410A1
Human necessities

Compositions and Methods for the Regulation of T Regulatory Cells Using TL1A-Ig Fusion Protein

#13 | 2014-02-06
US20140037682A1
Human necessities

HIV/SIV VACCINES FOR THE GENERATION OF MUCOSAL AND SYSTEMIC IMMUNITY

#14 | 2013-11-14
US20130302376A1
Human necessities

Allogeneic cancer cell-based immunotherapy

#15 | 2012-12-27
US20120328559A1
Chemistry; metallurgy

Compositions and Methods for Treating Inflammatory Lung Disease

#16 | 2012-12-20
US20120321645A1
Human necessities

Immunomodulating tumor necrosis factor receptor 25 (TNFR25) agonists, antagonists, and immunotoxins

#17 | 2012-05-31
US20120135011A1
Chemistry; metallurgy

Method for in vivo expansion of T regulatory cells

#18 | 2011-11-24
US20110287057A1
Human necessities

Cancer Treatment

#19 | 2011-10-13
US20110250229A1
Human necessities

Allogeneic cancer cell-based immunotherapy

#20 | 2011-10-06
US20110243951A1
Human necessities

IMMUNOMODULATING TUMOR NECROSIS FACTOR RECEPTOR 25 (TNFR25) AGONISTS, ANTAGONISTS AND IMMUNOTOXINS

#21 | 2011-09-15
US20110223196A1
Human necessities

HIV/SIV VACCINES FOR THE GENERATION OF MUCOSAL AND SYSTEMIC IMMUNITY

#22 | 2011-08-11
US20110195048A1
Chemistry; metallurgy

REGULATION OF LYMPHOCYTES AND USES THEREFOR

#23 | 2011-07-14
US20110171211A1
Human necessities

Heat shock protein GP96 vaccination and methods of using same

#24 | 2009-06-25
US20090162404A1
Chemistry; metallurgy

Tumor vaccine

#25 | 2009-06-04
US20090142768A1
Chemistry; metallurgy

PERFORIN-2 PROTEINS

#26 | 2008-01-31
US20080026012A1
Human necessities

Recombinant cancer cell secreting modified heat shock protein-antigenic peptide complex

#27 | 2008-01-03
US20080003221A1
Chemistry; metallurgy

Compositions and methods for treating inflammatory lung disease

InventorID:

528392 ⎘